182 related articles for article (PubMed ID: 25499536)
1. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.
Green RC; Christensen KD; Cupples LA; Relkin NR; Whitehouse PJ; Royal CD; Obisesan TO; Cook-Deegan R; Linnenbringer E; Butson MB; Fasaye GA; Levinson E; Roberts JS;
Alzheimers Dement; 2015 Oct; 11(10):1222-30. PubMed ID: 25499536
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.
Roberts JS; Chen CA; Uhlmann WR; Green RC
Genet Med; 2012 Aug; 14(8):742-8. PubMed ID: 22498844
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.
Christensen KD; Uhlmann WR; Roberts JS; Linnenbringer E; Whitehouse PJ; Royal CDM; Obisesan TO; Cupples LA; Butson MB; Fasaye GA; Hiraki S; Chen CA; Siebert U; Cook-Deegan R; Green RC
Genet Med; 2018 Jan; 20(1):132-141. PubMed ID: 28726810
[TBL] [Abstract][Full Text] [Related]
4. Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.
Christensen KD; Roberts JS; Whitehouse PJ; Royal CD; Obisesan TO; Cupples LA; Vernarelli JA; Bhatt DL; Linnenbringer E; Butson MB; Fasaye GA; Uhlmann WR; Hiraki S; Wang N; Cook-Deegan R; Green RC;
Ann Intern Med; 2016 Feb; 164(3):155-63. PubMed ID: 26810768
[TBL] [Abstract][Full Text] [Related]
5. Disclosure of APOE genotype for risk of Alzheimer's disease.
Green RC; Roberts JS; Cupples LA; Relkin NR; Whitehouse PJ; Brown T; Eckert SL; Butson M; Sadovnick AD; Quaid KA; Chen C; Cook-Deegan R; Farrer LA;
N Engl J Med; 2009 Jul; 361(3):245-54. PubMed ID: 19605829
[TBL] [Abstract][Full Text] [Related]
6. Risk of dementia among white and African American relatives of patients with Alzheimer disease.
Green RC; Cupples LA; Go R; Benke KS; Edeki T; Griffith PA; Williams M; Hipps Y; Graff-Radford N; Bachman D; Farrer LA;
JAMA; 2002 Jan; 287(3):329-36. PubMed ID: 11790212
[TBL] [Abstract][Full Text] [Related]
7. Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry.
Alber J; Popescu D; Thompson LI; Tonini GM; Arthur E; Oh H; Correia S; Salloway SP; Lee AK
J Geriatr Psychiatry Neurol; 2022 May; 35(3):293-301. PubMed ID: 33550928
[TBL] [Abstract][Full Text] [Related]
8. Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.
Waterink L; Masselink LA; van der Lee SJ; Visser LNC; Cleutjens S; van der Schaar J; van Harten AC; Scheltens P; Sikkes SAM; van der Flier WM; Zwan MD
Alzheimers Res Ther; 2024 Jan; 16(1):1. PubMed ID: 38167083
[TBL] [Abstract][Full Text] [Related]
9. Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.
Cassidy MR; Roberts JS; Bird TD; Steinbart EJ; Cupples LA; Chen CA; Linnenbringer E; Green RC
Alzheimers Dement; 2008 Nov; 4(6):406-13. PubMed ID: 19012865
[TBL] [Abstract][Full Text] [Related]
10. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
[TBL] [Abstract][Full Text] [Related]
11. Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.
Vernarelli JA; Roberts JS; Hiraki S; Chen CA; Cupples LA; Green RC
Am J Clin Nutr; 2010 May; 91(5):1402-7. PubMed ID: 20219963
[TBL] [Abstract][Full Text] [Related]
12. Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.
Blue EE; Cheng A; Chen S; Yu CE;
JAMA Netw Open; 2020 Oct; 3(10):e2017666. PubMed ID: 33090224
[TBL] [Abstract][Full Text] [Related]
13. Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).
Largent EA; Bhardwaj T; Abera M; Stites SD; Harkins K; Lerner AJ; Bradbury AR; Karlawish J
J Alzheimers Dis; 2021; 84(3):1015-1028. PubMed ID: 34602479
[TBL] [Abstract][Full Text] [Related]
14. Association of apolipoprotein E genotype and Alzheimer disease in African Americans.
Murrell JR; Price B; Lane KA; Baiyewu O; Gureje O; Ogunniyi A; Unverzagt FW; Smith-Gamble V; Gao S; Hendrie HC; Hall KS
Arch Neurol; 2006 Mar; 63(3):431-4. PubMed ID: 16533971
[TBL] [Abstract][Full Text] [Related]
15. Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.
Ashida S; Koehly LM; Roberts JS; Chen CA; Hiraki S; Green RC
J Health Commun; 2009 Dec; 14(8):768-84. PubMed ID: 20029710
[TBL] [Abstract][Full Text] [Related]
16. APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry.
Belloy ME; Andrews SJ; Le Guen Y; Cuccaro M; Farrer LA; Napolioni V; Greicius MD
JAMA Neurol; 2023 Dec; 80(12):1284-1294. PubMed ID: 37930705
[TBL] [Abstract][Full Text] [Related]
17. Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.
Bemelmans SA; Tromp K; Bunnik EM; Milne RJ; Badger S; Brayne C; Schermer MH; Richard E
Alzheimers Res Ther; 2016 Nov; 8(1):46. PubMed ID: 27832826
[TBL] [Abstract][Full Text] [Related]
18. Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.
Chao S; Roberts JS; Marteau TM; Silliman R; Cupples LA; Green RC
Alzheimer Dis Assoc Disord; 2008; 22(1):94-7. PubMed ID: 18317253
[TBL] [Abstract][Full Text] [Related]
19. Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.
Bradbury AR; Patrick-Miller LJ; Egleston BL; Hall MJ; Domchek SM; Daly MB; Ganschow P; Grana G; Olopade OI; Fetzer D; Brandt A; Chambers R; Clark DF; Forman A; Gaber R; Gulden C; Horte J; Long JM; Lucas T; Madaan S; Mattie K; McKenna D; Montgomery S; Nielsen S; Powers J; Rainey K; Rybak C; Savage M; Seelaus C; Stoll J; Stopfer JE; Yao XS
J Natl Cancer Inst; 2018 Sep; 110(9):985-993. PubMed ID: 29490071
[TBL] [Abstract][Full Text] [Related]
20. Characterizing Clinical and Neuropathological Traits of APOE Haplotypes in African Americans and Europeans.
Mezlini AM; Magdamo C; Merrill E; Chibnik LB; Blacker DL; Hyman BT; Das S
J Alzheimers Dis; 2020; 78(1):467-477. PubMed ID: 33016904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
